← Back to Clinical Trials
Recruiting NCT07647354

NCT07647354 Mako-MORE Registry

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07647354
Status Recruiting
Phase
Sponsor Stryker Orthopaedics
Condition Arthropathy of Knee
Study Type OBSERVATIONAL
Enrollment 950 participants
Start Date 2026-07-13
Primary Completion 2033-05-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Mako Robotic-Arm Assisted Arthroplasty

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 950 participants in total. It began in 2026-07-13 with a primary completion date of 2033-05-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is a prospective, post-market, multi-center, registry-based observational study designed to collect real-world clinical data on patients undergoing joint arthroplasty with Stryker implants, with or without the use of the Mako Robotic-Arm Assisted System. The registry will collect prospective data on patient characteristics, procedural details, patient-reported outcomes, radiographic assessments, and adverse events. Patients will be enrolled into procedure-specific cohorts and followed for up to five years postoperatively.

Eligibility Criteria

Inclusion Criteria: * The subject is skeletally mature, and ≥ 18 years old. * The Subject has signed and dated an IRB/EC approved, study specific Informed Patient Consent Form (ICF). * The subject is scheduled to undergo manual arthroplasty or Mako Robotic-Arm Assisted Arthroplasty according to IFU. * The subject is willing and able to comply with postoperative scheduled clinical evaluations. Exclusion Criteria: * The subject is not able to express his/her consent as deemed by the investigator. * The subject is not able to fulfill a self-assessment questionnaire or follow-up visits as deemed by the investigator. * The subject is a prisoner. * Per surgeon discretion the subject is not a candidate for the study. * The subject is pregnant or breastfeeding.

Contact & Investigator

Central Contact

Yonandy Barrientos

✉ yonandy.barrientos@stryker.com

📞 347-281-3196

Frequently Asked Questions

Who can join the NCT07647354 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Arthropathy of Knee. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07647354 currently recruiting?

Yes, NCT07647354 is actively recruiting participants. Contact the research team at yonandy.barrientos@stryker.com for enrollment information.

Where is the NCT07647354 trial being conducted?

This trial is being conducted at Jacksonville, United States, Louisville, United States, New York, United States, Cleveland, United States and 1 additional location.

Who is sponsoring the NCT07647354 clinical trial?

NCT07647354 is sponsored by Stryker Orthopaedics. The trial plans to enroll 950 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology